1. Home
  2. PAHC vs GRDN Comparison

PAHC vs GRDN Comparison

Compare PAHC & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • GRDN
  • Stock Information
  • Founded
  • PAHC 1946
  • GRDN 2004
  • Country
  • PAHC United States
  • GRDN United States
  • Employees
  • PAHC N/A
  • GRDN N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • GRDN Retail-Drug Stores and Proprietary Stores
  • Sector
  • PAHC Health Care
  • GRDN Consumer Staples
  • Exchange
  • PAHC Nasdaq
  • GRDN Nasdaq
  • Market Cap
  • PAHC 1.5B
  • GRDN 1.7B
  • IPO Year
  • PAHC 2014
  • GRDN 2024
  • Fundamental
  • Price
  • PAHC $41.19
  • GRDN $28.55
  • Analyst Decision
  • PAHC Hold
  • GRDN Strong Buy
  • Analyst Count
  • PAHC 4
  • GRDN 2
  • Target Price
  • PAHC $27.50
  • GRDN $30.00
  • AVG Volume (30 Days)
  • PAHC 232.9K
  • GRDN 278.8K
  • Earning Date
  • PAHC 11-05-2025
  • GRDN 11-10-2025
  • Dividend Yield
  • PAHC 1.17%
  • GRDN N/A
  • EPS Growth
  • PAHC 1895.04
  • GRDN N/A
  • EPS
  • PAHC 1.19
  • GRDN N/A
  • Revenue
  • PAHC $1,296,215,000.00
  • GRDN $1,326,604,000.00
  • Revenue This Year
  • PAHC $14.80
  • GRDN $16.33
  • Revenue Next Year
  • PAHC $3.16
  • GRDN $2.10
  • P/E Ratio
  • PAHC $34.61
  • GRDN N/A
  • Revenue Growth
  • PAHC 27.37
  • GRDN 18.53
  • 52 Week Low
  • PAHC $16.16
  • GRDN $17.29
  • 52 Week High
  • PAHC $42.82
  • GRDN $30.39
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 59.69
  • GRDN 66.07
  • Support Level
  • PAHC $38.95
  • GRDN $23.72
  • Resistance Level
  • PAHC $42.82
  • GRDN $24.86
  • Average True Range (ATR)
  • PAHC 1.69
  • GRDN 1.11
  • MACD
  • PAHC 0.13
  • GRDN 0.48
  • Stochastic Oscillator
  • PAHC 76.75
  • GRDN 79.91

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

Share on Social Networks: